<!doctype html>
<html lang="en-gb">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <title>Hereditary Epidermolysis Bullosa Information</title>
  <link rel="stylesheet" href="css/bootstrap.min.css" />
  <link rel="stylesheet" href="css/styles.css" />
  <style>
    /* Add top margin to move the content down */
    #content {
        margin-top: 100px; /* Adjust this value to control the distance moved downward */
    }
    /* Increase the distance between the button and the footer */
    .btn-primary {
        margin-bottom: 50px; /* Adjust this value to control the distance between the button and the footer */
    }
  </style>
</head>

<body>
<header class="header">
<div id="overview" class="container">
  <nav class="navbar navbar-inverse" role="navigation">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#main-nav">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a href="index.html" class="navbar-brand logo"><b>Rare<i>Insight</i></b></a>
    </div>
    <div id="main-nav" class="collapse navbar-collapse">
      <ul class="nav navbar-nav">
        <li class="active" id="firstLink"><a href="epidermolysis-bullosa.html" class="scroll-link">Overview</a></li>
        <li><a href="#articles" class="scroll-link">Articles</a></li>
        <li><a href="#team" class="scroll-link">Hospitals & Specialists</a></li>
        <li><a href="#groups" class="scroll-link">Patient Groups & Foundations</a></li>
        <li><a href="index.html" class="scroll-link">Back to Home</a></li>
      </ul>
    </div>
  </nav>
</div>
</header>
<section id="content">
<div class="container">
  <div class="row">
    <div class="col-md-12">
      <h2 class="text-center">Prader-Willi Syndrome 普瑞德威利症候群</h2>
      <p><strong>Prader-Willi Syndrome (普瑞德威利症候群) is a rare genetic disorder caused by the loss of function of specific genes on chromosome 15. It affects multiple systems in the body and is primarily characterized by weak muscle tone, poor growth, excessive hunger, and intellectual and behavioral problems. Individuals with PWS often experience constant hunger, which can lead to obesity and related complications if not carefully managed.</strong></p>  
      
      <h3><b>Symptoms</b></h3>
      <p><strong>Symptoms of Prader-Willi Syndrome include:</strong></p>
      <ul>
        <li>Poor muscle tone (especially in infancy)</li>
        <li>Feeding difficulties in early infancy, followed by insatiable appetite in childhood</li>
        <li>Rapid weight gain and obesity</li>
        <li>Short stature and small hands/feet</li>
        <li>Developmental delays and learning difficulties</li>
        <li>Behavioral issues such as temper tantrums or obsessive-compulsive behaviors</li>
        <li>Delayed or incomplete puberty</li>
        <li>Sleep abnormalities</li>
        <li>Distinct facial features (e.g., almond-shaped eyes, narrow forehead)</li>
      </ul>

      <h3><b>Types of PWS</b></h3>
      <p><strong>Prader-Willi Syndrome is classified based on the genetic cause of the chromosome 15 abnormality:</strong></p>
      <ul>
        <li>Paternal deletion: A deletion on the father’s copy of chromosome 15 (most common cause).</li>
        <li>Maternal uniparental disomy (UPD): The child inherits two copies of chromosome 15 from the mother and none from the father.</li>
        <li>Imprinting defect: A problem in the gene's imprinting center affects gene expression on chromosome 15.</li>
      </ul>

      <h3><b>Causes</b></h3>
      <p>Prader-Willi Syndrome is caused by the absence of active genes in a specific region of the paternal chromosome 15 (15q11-q13). The disorder is not typically inherited but results from random genetic errors during conception. However, rare cases involving imprinting defects may be passed down.</p>

      <h3><b>Prevention and Care</b></h3>
      <p><strong>There is no way to prevent PWS, but early diagnosis and intervention can improve quality of life. Common care strategies include:</strong></p>
      <ul>
        <li>Strict supervision of food intake to prevent obesity</li>
        <li>Hormone therapy (such as growth hormone) to improve growth and muscle tone</li>
        <li>Special education and behavioral therapy</li>
        <li>Regular monitoring of physical and developmental health</li>
        <li>Supportive care to address sleep, behavior, and learning challenges</li>
      </ul>
      <br/>
      <br/>
      <br/>
    </div>
  </div>
</div>
</section>

<!-- Articles Section -->
<section id="articles">
<div class="container">
  <br/>
  <br/>
  <br/>
  <div class="heading text-center">
    <h2>Articles</h2>
    <p>Read the latest articles on Hereditary Epidermolysis Bullosa and related topics</p>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/34916041/" class="special-link"><b>Pathophysiology and therapeutic challenges</b></a></h4>
      <p>EB is a group of inherited skin disorders caused by gene mutations affecting the skin's structural integrity, and recent advancements in understanding the disease mechanisms have led to the development of promising therapies like gene and cell therapy.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://researchoutput.ncku.edu.tw/en/publications/epidermolysis-bullosa " class="special-link"><b>Epidermolysis Bullosa (NCKU)</b></a></h4>
      <p>Epidermolysis bullosa (EB) is a rare inherited skin disorder characterized by blistering from minimal trauma, with over 30 subtypes classified by molecular abnormalities, and while there is no cure, advancements in gene and cell therapies offer hope for future treatments.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/36578049/" class="special-link"><b>Mutational analysis of epidermolysis bullosa in Taiwan by whole</b></a></h4>
      <p>A study of 77 Taiwanese patients with epidermolysis bullosa (EB) identified 60 mutations, including 22 novel ones, demonstrating that whole-exome sequencing is an effective first-line diagnostic tool for EB, with RNA sequencing useful for identifying splice-site mutations.</p>
    </div>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/34916041/" class="special-link"><b>New Hope for Treating the 4 Main Types of Epidermolysis Bullosa</b></a></h4>
      <p>Recent advancements in the understanding of epidermolysis bullosa have resulted in a fine-tuning of the classification of the disease group as well as the development of new possible therapies.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.ncbi.nlm.nih.gov/books/NBK599531/" class="special-link"><b>Epidermolysis Bullosa (NIH)</b></a></h4>
      <p>Epidermolysis bullosa (EB) defines a prototypic group of rare, inherited dermatoses, characteristically featuring skin fragility secondary to structural defects in the dermo-epidermal junction.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3750879/" class="special-link"><b>Inherited epidermolysis bullosa: clinical and therapeutic aspects</b></a></h4>
      <p>Inherited epidermolysis bullosa (EB) is a heterogeneous group of genetic disorders that present with skin and, in some cases, mucosal fragility, predisposing patients to the development of blisters</p>
    </div>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/37276163/" class="special-link"><b>Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial</b></a></h4>
      <p>In epidermolysis bullosa simplex (EBS), epithelial structural fragility results in blisters and erosions. Diacerein 1% ointment has been shown to reduce this blistering.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.mdpi.com/2227-9032/12/2/261" class="special-link"><b>Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis</b></a></h4>
      <p>Epidermolysis bullosa (EB) is the overarching term for a set of rare inherited skin fragility disorders that result from mutations in at least 20 different genes.</p>
    </div>
    <div class="col-md-4"></div>
      <h4><a href="https://www.sciencedirect.com/science/article/pii/S0190962218301300" class="special-link"><b>Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial</b></a></h4>
      <p>Epidermolysis bullosa simplex (EBS) is a rare genetic, blistering skin disease for which there is no cure. Treatments that address the pathophysiology of EBS are needed.</p>
    </div>
  </div>
  <br/>
  <br/>
  <br/>
</div>
</section>

<!-- Doctors Section -->
<section id="team" class="page-section">
  <div class="container">
    <br/>
    <br/>
    <br/>
    <div class="heading text-center"> 
      <!-- Heading -->
      <h2>Hospital and Specialists</h2>
    </div>
    <br/>
    <!-- Doctor's Details -->
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Chao-Kai Hsu</h3>
        <h4>Chairman, Genetic Center at National Cheng Kung University Hospital</h4>
        <h4>Associate Professor, Department of Dermatology,  College of Medicine, National Cheng Kung University</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://researchoutput.ncku.edu.tw/en/persons/chao-kai-hsu/publications/">Research Publications</a></h4>
          <h4><a href="https://web.hosp.ncku.edu.tw/nckm/">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/Chao-Kai Hsu.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Nessa Aghazadeh Mohandesi</h3>
        <h4>Dermatologist, Pediatric Dermatologist</h4>
        <h4>Children's Center Department, Pediatric and Adolescent Medicine Department, Dermatology Department, Clinical Genomics Department</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.mayoclinic.org/biographies/aghazadeh-mohandesi-nessa-m-d/bio-20550820">Research Publications</a></h4>
          <h4><a href="https://www.mayoclinic.org/patient-visitor-guide/minnesota/campus-buildings-maps/mayo-gonda-buildings?mc_id=us&utm_source=yext&utm_medium=l&utm_content=feature&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=102372&y_source=1_MzkxODQ2OC03MTUtbG9jYXRpb24ud2Vic2l0ZQ%3D%3D">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/Nessa_Aghazadeh_Mohandesi.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>John W. Frew</h3>
        <h4>Dermatologist</h4>
        <h4>The Rockefeller University</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Training at St. John's Institute of Dermatology, King's College London (under Prof. John McGrath & Dr. Eduardo Calonje)</li>
          <li>Short-term training in Dermatology, Hokkaido University, Japan (under Prof. Hiroshi Shimizu)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.medifind.com/doctors/john-w-frew/8407643">Research Publications</a></h4>
          <h4><a href="https://www.google.com/maps/place/1230+York+Ave,+New+York,+NY+10065%E7%BE%8E%E5%9C%8B/@40.7624486,-73.9560867,17z/data=!3m1!4b1!4m6!3m5!1s0x89c259ec9988a2f5:0xa452c574fb96e8b!8m2!3d40.7624486!4d-73.9560867!16s%2Fg%2F11y741rthc?entry=ttu&g_ep=EgoyMDI0MTEwNi4wIKXMDSoASAFQAw%3D%3D">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/John W. Frew.jpg" alt="" width="160%"> </div>
    </div>
    <br/>
    <br/>
    <br/>
  </div>
  <!--/.container--> 
</section>

<!-- Function Section -->
<section id="groups">
<div class="container">
  <br/>
  <br/>
  <div class="heading text-center">
    <!-- Heading -->
    <h2>Patient Groups & Foundations</h2>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://www.eb-researchnetwork.org/about-us/network-partners/" class="special-link"><b>EB Research Network</b></a></h4>
      <p>The EB Research Network is a collaborative global network of organizations, researchers, and advocates working together to advance research and find treatments for Epidermolysis Bullosa.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.debra.org/" class="special-link"><b>Debra of America</b></a></h4>
      <p>Debra of America is a nonprofit organization dedicated to supporting people affected by Epidermolysis Bullosa (EB) through advocacy, research funding, and resources for individuals and families.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="http://www.eb.org.tw/ap/index.aspx " class="special-link"><b>Taiwan EB Association</b></a></h4>
      <p>The EB Association Taiwan is dedicated to improving the lives of individuals affected by Epidermolysis Bullosa (EB) in Taiwan through advocacy, support services, and raising awareness of this rare genetic condition.</p>
    </div>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    
    <a href="index.html" class="btn btn-primary">Back to Home</a>
  </div>
</div>
</section>

<footer>
<div class="container text-center">
  <p>&copy; 2024 RareInsight. All rights reserved.</p>
</div>
</footer>

<script src="js/jquery-1.8.
